Seeing Is Believing
Currently out of the existing stock ratings of Debjit Chattopadhyay, 202 are a BUY (90.58%), 21 are a HOLD (9.42%).
Analyst Debjit Chattopadhyay, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 48.05% that have a potential upside of 39.02% achieved within 242 days.
Debjit Chattopadhyay’s has documented 437 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on CNTA, Centessa Pharmaceuticals PLC ADR at 02-Apr-2026.
Analyst best performing recommendations are on PEPG (PEPGEN LTD).
The best stock recommendation documented was for PEPG (PEPGEN LTD) at 9/9/2025. The price target of $6 was fulfilled within 77 days with a profit of $4.52 (305.41%) receiving and performance score of 39.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Jan-2026
$25
$7.84 (45.69%)
$31
13 days ago
(23-Mar-2026)
3/6 (50%)
$9.08 (57.04%)
1245
Hold Since 11-Mar-2026
$35
$17.84 (103.96%)
$12
25 days ago
(11-Mar-2026)
4/6 (66.67%)
$17.44 (99.32%)
59
Buy Since 22-Dec-2020
$70
$52.84 (307.93%)
$70
26 days ago
(10-Mar-2026)
12/19 (63.16%)
$51.74 (283.35%)
305
Hold Since 09-Mar-2026
$60
$42.84 (249.65%)
$15
27 days ago
(09-Mar-2026)
4/7 (57.14%)
$42.01 (233.52%)
88
Buy Since 01-Apr-2025
$31
$13.84 (80.65%)
$16
27 days ago
(09-Mar-2026)
7/10 (70%)
$13.01 (72.32%)
89
Which stock is Debjit Chattopadhyay is most bullish on?
Which stock is Debjit Chattopadhyay is most reserved on?
What Year was the first public recommendation made by Debjit Chattopadhyay?